Positive News SentimentPositive NewsNASDAQ:KRRO Korro Bio (KRRO) Stock Price, News & Analysis $41.58 +1.14 (+2.82%) (As of 09:38 AM ET) Add Compare Share Share Today's Range$40.34▼$42.1650-Day Range$34.41▼$52.4852-Week Range$9.15▼$97.91Volume10,884 shsAverage Volume51,345 shsMarket Capitalization$386.69 millionP/E RatioN/ADividend YieldN/APrice Target$135.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Korro Bio alerts: Email Address Korro Bio MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside224.7% Upside$135.00 Price TargetShort InterestHealthy4.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($10.29) to ($11.15) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.41 out of 5 starsMedical Sector600th out of 932 stocksPharmaceutical Preparations Industry281st out of 433 stocks 3.5 Analyst's Opinion Consensus RatingKorro Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageKorro Bio has only been the subject of 3 research reports in the past 90 days.Read more about Korro Bio's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.87% of the float of Korro Bio has been sold short.Short Interest Ratio / Days to CoverKorro Bio has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Korro Bio has recently decreased by 2.47%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldKorro Bio does not currently pay a dividend.Dividend GrowthKorro Bio does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KRRO. Previous Next 3.8 News and Social Media Coverage News SentimentKorro Bio has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Korro Bio this week, compared to 1 article on an average week.Search Interest4 people have searched for KRRO on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows2 people have added Korro Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Korro Bio insiders have not sold or bought any company stock.Percentage Held by Insiders16.80% of the stock of Korro Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 13.18% of the stock of Korro Bio is held by institutions.Read more about Korro Bio's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Korro Bio are expected to decrease in the coming year, from ($10.29) to ($11.15) per share.Price to Book Value per Share RatioKorro Bio has a P/B Ratio of 1.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Korro Bio's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About Korro Bio Stock (NASDAQ:KRRO)Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.Read More KRRO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KRRO Stock News HeadlinesSeptember 4, 2024 | finance.yahoo.comWill Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?September 3, 2024 | americanbankingnews.comKorro Bio, Inc. (NASDAQ:KRRO) Short Interest UpdateSeptember 13, 2024 | Crypto 101 Media (Ad)Last Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And this fear has caused the entire crypto market to plunge. But everyone is forgetting one thing…Bitcoin was created in the aftermath of the 2008 financial crisis. August 28, 2024 | markets.businessinsider.comKorro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of DirectorsAugust 27, 2024 | globenewswire.comKorro to Participate in Upcoming September Investor and Scientific ConferencesAugust 16, 2024 | uk.investing.comKorro Bio stock poised for growth with upcoming clinical validation - Piper SandlerAugust 15, 2024 | msn.comGene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform RatingAugust 15, 2024 | msn.comWilliam Blair Initiates Coverage of Korro Bio (KRRO) with Outperform RecommendationSeptember 13, 2024 | Crypto 101 Media (Ad)Last Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And this fear has caused the entire crypto market to plunge. But everyone is forgetting one thing…Bitcoin was created in the aftermath of the 2008 financial crisis. August 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Korro Bio (KRRO) and Gilead Sciences (GILD)August 13, 2024 | globenewswire.comKorro Reports Second Quarter 2024 Financial Results and Provides Business UpdatesJuly 19, 2024 | morningstar.comKorro Bio Inc KRROJune 25, 2024 | investorplace.comKRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023May 30, 2024 | globenewswire.comKorro to Participate in Upcoming June Investor and Scientific ConferencesMay 21, 2024 | markets.businessinsider.comBuy Rating Affirmed for Korro Bio Amid Promising KRRO-110 Preclinical Data and Superior Therapeutic ProfileMay 20, 2024 | globenewswire.comKorro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International ConferenceMay 18, 2024 | finance.yahoo.comKorro Bio, Inc. (KRRO)May 15, 2024 | markets.businessinsider.comKorro Bio Earns Buy Rating from Analyst Mitchell Kapoor on Groundbreaking RNA Editing Technology and Strong Preclinical ResultsSee More Headlines Receive KRRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/13/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:KRRO Previous SymbolNASDAQ:KRRO CUSIPN/A CIK1703647 Webwww.frequencytx.com Phone781-315-4600FaxN/AEmployees70Year FoundedN/APrice Target and Rating Average Stock Price Target$135.00 High Stock Price Target$180.00 Low Stock Price Target$95.00 Potential Upside/Downside+233.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-81,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-61.36% Return on Assets-47.68% Debt Debt-to-Equity RatioN/A Current Ratio13.28 Quick Ratio13.28 Sales & Book Value Annual Sales$14.07 million Price / Sales26.73 Cash FlowN/A Price / Cash FlowN/A Book Value$21.19 per share Price / Book1.91Miscellaneous Outstanding Shares9,300,000Free Float7,715,000Market Cap$376.09 million OptionableNo Data Beta2.17 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Nessan Bermingham Ph.D. (Age 51)Co-Founder & Executive Chairman Comp: $202.14kMr. Ram Aiyar MBA (Age 46)Ph.D., CEO, President & Director Comp: $844.87kDr. Jean-Francois Formela M.D. (Age 67)MBA, Co-Founder & Director Comp: $8.21kMr. Vineet Agarwal M.B.A. (Age 42)Chief Financial Officer Comp: $811.77kDr. Steven L. Colletti Ph.D. (Age 58)Chief Scientific Officer Comp: $592.89kMr. Andrew Fraley Ph.D.Co-Founder & CTOMr. Josh Rosenthal Ph.D.Co-Founder & AdvisorMr. Todd Chappell (Age 51)Chief Operating Officer Ms. Shelby Walker J.D. (Age 49)Senior VP & General Counsel Mr. Ravi Ramadas Ph.D.Vice President of Business & Corporate DevelopmentMore ExecutivesKey CompetitorsAvadel PharmaceuticalsNASDAQ:AVDLLongboard PharmaceuticalsNASDAQ:LBPHArdelyxNASDAQ:ARDXOcular TherapeutixNASDAQ:OCULCassava SciencesNASDAQ:SAVAView All CompetitorsInsiders & InstitutionsPoint72 Asset Management L.P.Bought 190,259 shares on 8/19/2024Ownership: 4.918%Driehaus Capital Management LLCBought 116,858 shares on 8/16/2024Ownership: 1.260%Millennium Management LLCBought 23,307 shares on 8/15/2024Ownership: 0.908%Lynx1 Capital Management LPBought 3,800 shares on 8/15/2024Ownership: 0.041%Marshall Wace LLPSold 4,304 shares on 8/14/2024Ownership: 0.098%View All Insider TransactionsView All Institutional Transactions KRRO Stock Analysis - Frequently Asked Questions How have KRRO shares performed this year? Korro Bio's stock was trading at $47.93 at the beginning of 2024. Since then, KRRO shares have decreased by 13.2% and is now trading at $41.58. View the best growth stocks for 2024 here. How were Korro Bio's earnings last quarter? Korro Bio, Inc. (NASDAQ:KRRO) posted its earnings results on Tuesday, August, 13th. The company reported ($2.43) earnings per share for the quarter, missing analysts' consensus estimates of ($2.39) by $0.04. Who are Korro Bio's major shareholders? Top institutional investors of Korro Bio include Atlas Venture Life Science Advisors LLC (12.26%), NEA Management Company LLC (11.76%), Point72 Asset Management L.P. (4.92%) and Driehaus Capital Management LLC (1.26%). Insiders that own company stock include Venture Opportunity Fund Atlas and David L Lucchino. View institutional ownership trends. How do I buy shares of Korro Bio? Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:KRRO) was last updated on 9/13/2024 by MarketBeat.com Staff From Our PartnersInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredYou won’t believe what this ex-Wall Street insider discovered about the electionOne ex-Wall Street insider recently combed through 64 years of election data… And he just uncovered somethi...Banyan Hill Publishing | SponsoredTesla of the Skies? SRFM Takes FlightThe future of transportation is taking flight—literally. Market JAR | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredAmerica dodged a crisis — next time it could be much worseLegendary financial forecaster, Dr. Martin Weiss, has been warning us about it for months … He believes the...Weiss Ratings | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts